Here are the DEF 14A proxy statements from Traws Pharma, Inc. (TRAW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow TRAW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRAW filings page.
Traws Pharma, Inc. asks stockholders at its December 3, 2026 special meeting to authorize a 1-for-8 to 1-for-15 reverse split of common stock. If approved, the board could set the ratio and implement the split within 12 months after approval, without another stockholder vote, or abandon it. The company identifies Nasdaq’s $1.00 minimum bid-price requirement as one main reason for the proposal.
Traws Pharma received a Nasdaq deficiency notice after its closing bid price was below $1.00 for at least 30 consecutive business days and has until January 25, 2027 to regain compliance. The company says its stock could be delisted if stockholders reject the proposal and that a split would not assure continued listing. Authorized common shares would remain at 250,000,000; future issuance of authorized shares could dilute existing holders. The board recommends voting for both proposals, including adjournment to solicit additional proxies if needed.
Traws Pharma, Inc. is asking stockholders to vote on key governance and equity proposals at its 2026 virtual annual meeting on July 8, 2026. Holders of 15,150,669 common shares as of May 18, 2026 can participate and vote online.
Stockholders will elect seven directors and consider amending the 2021 Incentive Compensation Plan to add 2,000,000 shares for future equity awards and make administrative updates. They are also asked to ratify KPMG LLP as auditor, approve share issuance upon exercise of Series B and Series C warrants under Nasdaq Listing Rule 5635(d), and authorize potential adjournment to gather additional votes.